SSIEM 2019 Symposium

Society for the Study of Inborn Errors of Metabolism

September 3-6, 2019

Rotterdam, The Netherlands

Baebies at SSIEM

  • Join the Baebies team at SSIEM 2019 to discuss:
    • Baebies SEEKER, the first FDA-cleared and CE-marked newborn screening platform for LSDs including Pompe disease, MPS I, Fabry and Gaucher
    • Additional tests including BIOT, GALT, MPS II, Krabbe, Duchenne Muscular Dystrophy, and Niemann-Pick
    • Second tier sequencing services provided in our CLIA lab
  • Request a meeting (see form to the right) or visit our exhibit booth.
  • Want to attend the conference? Go to the SSIEM 2019 website for event details and registration.
  • For more on LSD neonatal screening with digital microfluidics, view this IJNS peer-reviewed publication “Current State of the Art of Newborn Screening for Lysosomal Storage Disorders”.
  • If you are interested in worldwide NBS, see our interview with Dr. Therrell “Global Expansion of Newborn Screening”.